Thursday, June 5, 2014

Biotherapeutics: The Next Wave of Healing


The study of mesotherapy and mesoreflexotherapy is all about treating your patients with biotherapeutics. These are designer injectibles that are also sometimes called biotech drugs, biosimilar drugs or biologics. They represent an entirely new generation of treatments that are derived from living cells or modified protein products.

It is important to understand that biosimilar drugs, also called bio-identical drugs, are in a subcategory of their own. They will never be an exact copy of the original drug. They have a multiple structure, rather than a single structure that can contain an exact copy of the exact active pharmaceutical ingredient (API).  They are also referred to as similar biotherapeutic products, subsequent entry biologics and follow-on biologics.

When you decide to take one of the Pinewood courses in mesotherapy you are participating in learning how to administer one of the most innovative new medicines for healing including the treatment of cancer, multiple sclerosis and rheumatoid arthritis.

A Bit of Background About Biotherapeutics

Insulin was one of the first biotherapeutic drugs
Biotherapeutics have been around for about thirty years. Of the many mass produced medicines used in biotherapy, insulin injections for diabetics was one of the first of the them to be produced en masse.  Since then, these medicines, that are manufactured under these very strict regulatory processes, have been used to treat all kinds of conditions including cancer, multiple sclerosis and heart disease.

One of the reasons is that there must be strict quality control during the production of biotherepeutic medicines is because they are often complex compounds that are larger.  Many biotherapeutic injectibles are also very sensitive to the conditions of their environment.

Thousands of these medicines are now being developed and many take a while to reach the market as the legal process of assigning intellectual copyright to them is so painstaking. 

Biotherapeutic Versus Chemically Synthesized Medicines

The main difference between biotherapeutic medicines and chemical ones are that that biotherapeutic medicines are based on proteins such as insulin, growth hormone and antibodies and are produced by living organisms such as cell, yeast and bacteria. This means that they consist of larger more complex molecules than chemical medicines, which consist of smaller molecules.   The fact that they are so dependent on a living source for synthesis and identification means that their process of manufacture is so much more complex then small molecule medicines that are mass produced from chemicals with comparatively very simple compounds.  This also makes them more expensive as well.

Biothereapeutic medicines are also distinct from the usual chemically-made medicines because they are more targeted to fight the condition. They are designed to have a specific mechanism of action in the body rather than a more general one as is the case with chemically synthesized substances.

The bottom line is that the production of biologic medicines is complex and that it is part of your responsibility as an administrator of these shots to have an educated awareness of how these variable medicines might interact with the physiology of the human body.  These are matters that are thoroughly covered in our courses on Mesotherapy.


For more information about The Pinewood Institute for the Advancement of Natural Medicine courses including course outlines, detailed descriptions of courses and  information about upcoming training sessions, please go www.pinewoodinstitute.com.  You can also send us an email using our email form at http://pinewoodinstitute.com/contact.aspx or call us at 416-656-8100. If you prefer fax the number is 416-656-8107.

No comments :

Post a Comment